相关实验视频
Updated: May 12, 2026

A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
由NFE2驱动的中性细胞两极化促进胰腺癌的进展,肝脏转移的进展
Wenchao Xu1, Jianzhou Liu1, Qiaofei Liu1
1Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing 100730, China; National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, Beijing 100730, China; State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
研究人员将中性粒细胞_S100A12细胞确定为胰腺癌肝转移的关键驱动因素. 核系红色素2 (NFE2) 调节中性粒细胞的两极分化,促进瘤的扩散,并建议新的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 胰腺癌肝脏转移显著恶化患者的预后.
- 适应性免疫反应,特别是中性粒细胞参与,在肝转移并未得到充分理解.
研究的目的:
- 为了阐明胰腺癌肝转移中的免疫重塑机制.
- 为了确定关键的细胞参与者和驱动中性粒细胞转移前功能的分子通路.
主要方法:
- 结合单细胞测序和空间转录组学.
- 在初级瘤中对转录特征和免疫细胞透的分析与肝转移.
- 研究转录因子NFE2及其在中性粒细胞两极分化中的作用.
主要成果:
- 与原发性瘤相比,肝转移表现出更具侵略性的转录特征和增加的免疫抑制.
- 表达S100结合蛋白A12 (S100A12) 的中性粒细胞被确定为侵袭前线的前转移性.
- 转化生长因子β激活中性粒细胞中的SMAD3通路,导致NFE2驱动的极化和中性粒细胞外细胞陷的产生.
结论:
- NFE2是一种关键的转录因子,调节了胰腺癌肝脏转移中的中性粒细胞两极化和前转移性活性.
- 由NFE2驱动的中性粒细胞极化,导致中性粒细胞外细胞陷的形成,是促进肝转移的关键机制.
- 针对NFE2驱动的中性粒细胞两极分化,可以作为对抗胰腺癌肝转移的潜在治疗策略.
更多相关视频
14:04Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
相关概念视频
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology